82_FR_42880 82 FR 42706 - Notification of a Public Meeting of the President's Commission on Combating Drug Addiction and the Opioid Crisis (Commission)

82 FR 42706 - Notification of a Public Meeting of the President's Commission on Combating Drug Addiction and the Opioid Crisis (Commission)

EXECUTIVE OFFICE OF THE PRESIDENT
Office of National Drug Control Policy

Federal Register Volume 82, Issue 174 (September 11, 2017)

Page Range42706-42706
FR Document2017-19186

ONDCP announces the third meeting of the President's Commission on Combating Drug Addiction and the Opioid Crisis to advance the Commission's work on drug issues and the opioid crisis per Executive Order 13784. The meeting will consist of statements to the Commission from invited government, nonprofit, and business organizations regarding Innovative Pain Management and Prevention Measures for Diversion followed by discussion of the issues raised.

Federal Register, Volume 82 Issue 174 (Monday, September 11, 2017) 
[Federal Register Volume 82, Number 174 (Monday, September 11, 2017)]
[Notices]
[Page 42706]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-19186]


=======================================================================
-----------------------------------------------------------------------

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control Policy


Notification of a Public Meeting of the President's Commission on 
Combating Drug Addiction and the Opioid Crisis (Commission)

AGENCY: Office of National Drug Control Policy (ONDCP), Executive 
Office of the President.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: ONDCP announces the third meeting of the President's 
Commission on Combating Drug Addiction and the Opioid Crisis to advance 
the Commission's work on drug issues and the opioid crisis per 
Executive Order 13784. The meeting will consist of statements to the 
Commission from invited government, nonprofit, and business 
organizations regarding Innovative Pain Management and Prevention 
Measures for Diversion followed by discussion of the issues raised.

DATES: The Commission meeting will be held on Wednesday September 27, 
2017 from 12:30 p.m. until approximately 2:30 p.m. (Eastern Time).

ADDRESSES: The meeting will be held at the Eisenhower Executive Office 
Building, Room 350, in the Executive Office of the President in 
Washington, DC. It will be open to the public through livestreaming on 
https://www.whitehouse.gov/live.

FOR FURTHER INFORMATION CONTACT: General information concerning the 
Commission and its meetings can be found on ONDCP's Web site at https://www.whitehouse.gov/ondcp/presidents-commission. Any member of the 
public who wishes to obtain information about the Commission or its 
meetings that is not already on ONDCP's Web site or who wishes to 
submit written comments for the Commission's consideration may contact 
Michael Passante, Designated Federal Officer (DFO) via email at 
[email protected] or telephone at (202) 395-6709. Please note 
that ONDCP may post such written comments publicly on our Web site, 
including names and contact information that are submitted. There will 
not be oral comments from the public at the meeting. Requests to 
accommodate disabilities with respect to livestreaming or otherwise 
should also be sent to that email address, preferably at least 10 days 
prior to the meeting to allow time for processing.

SUPPLEMENTARY INFORMATION: The Commission was established in accordance 
with E.O. 13784 of March 29, 2017, the Commission's charter, and the 
provisions of the Federal Advisory Committee Act (FACA), as amended, 5 
U.S.C. App. 2, to obtain advice and recommendations for the President 
regarding drug issues. The Executive Order, charter, and information on 
the Members of the Commission are available on ONDCP's Web site. The 
Commission will function solely as an advisory body and will make 
recommendations regarding policies and practices for combating drug 
addiction with particular focus on the current opioid crisis in the 
United States. The Commission's final report is due October 1, 2017 
unless there is an extension. Per E.O. 13784, the Commission shall:
    a. Identify and describe the existing Federal funding used to 
combat drug addiction and the opioid crisis;
    b. assess the availability and accessibility of drug addiction 
treatment services and overdose reversal throughout the country and 
identify areas that are underserved;
    c. identify and report on best practices for addiction prevention, 
including healthcare provider education and evaluation of prescription 
practices, collaboration between State and Federal officials, and the 
use and effectiveness of State prescription drug monitoring programs;
    d. review the literature evaluating the effectiveness of 
educational messages for youth and adults with respect to prescription 
and illicit opioids;
    e. identify and evaluate existing Federal programs to prevent and 
treat drug addiction for their scope and effectiveness, and make 
recommendations for improving these programs; and
    f. make recommendations to the President for improving the Federal 
response to drug addiction and the opioid crisis.

    Dated: September 6, 2017.
Michael Passante,
Deputy General Counsel, Designated Federal Officer.
[FR Doc. 2017-19186 Filed 9-8-17; 8:45 am]
 BILLING CODE 3280-F5-P

42706 Federal Register / Vol. 82, No. 174 / Monday, September 11, 2017 / Notices including the validity of the Dated: September 6, 2017. public at the meeting. Requests to methodology and assumptions used; Melody Braswell, accommodate disabilities with respect —Evaluate whether and if so how the Department Clearance Officer for PRA, U.S. to livestreaming or otherwise should quality, utility, and clarity of the Department of Justice. also be sent to that email address, information to be collected can be [FR Doc. 2017–19132 Filed 9–8–17; 8:45 am] preferably at least 10 days prior to the enhanced; and BILLING CODE 4410–FY–P meeting to allow time for processing. —Minimize the burden of the collection SUPPLEMENTARY INFORMATION: The of information on those who are to Commission was established in respond, including through the use of EXECUTIVE OFFICE OF THE accordance with E.O. 13784 of March appropriate automated, electronic, PRESIDENT 29, 2017, the Commission’s charter, and mechanical, or other technological Office of National Drug Control Policy the provisions of the Federal Advisory collection techniques or other forms Committee Act (FACA), as amended, 5 of information technology, e.g., Notification of a Public Meeting of the U.S.C. App. 2, to obtain advice and permitting electronic submission of responses. President’s Commission on Combating recommendations for the President Drug Addiction and the Opioid Crisis regarding drug issues. The Executive Overview of This Information (Commission) Order, charter, and information on the Collection Members of the Commission are AGENCY: Office of National Drug Control available on ONDCP’s Web site. The 1. Type of Information Collection Policy (ONDCP), Executive Office of the (check justification or form 83): Commission will function solely as an President. advisory body and will make Revision of a currently approved ACTION: Notice of meeting. recommendations regarding policies collection. 2. The Title of the Form/Collection: and practices for combating drug SUMMARY: ONDCP announces the third Application and Permit for Temporary addiction with particular focus on the meeting of the President’s Commission Importation of Firearms and on Combating Drug Addiction and the current opioid crisis in the United Ammunition By Nonimmigrant Aliens. Opioid Crisis to advance the States. The Commission’s final report is 3. The agency form number, if any, Commission’s work on drug issues and due October 1, 2017 unless there is an and the applicable component of the the opioid crisis per Executive Order extension. Per E.O. 13784, the Department sponsoring the collection: 13784. The meeting will consist of Commission shall: Form number (if applicable): ATF F statements to the Commission from a. Identify and describe the existing 6NIA (5330.3D). invited government, nonprofit, and Federal funding used to combat drug Component: Bureau of Alcohol, business organizations regarding addiction and the opioid crisis; Tobacco, Firearms and Explosives, U.S. Innovative Pain Management and b. assess the availability and Department of Justice. Prevention Measures for Diversion accessibility of drug addiction treatment 4. Affected public who will be asked followed by discussion of the issues services and overdose reversal or required to respond, as well as a brief raised. throughout the country and identify abstract: DATES: The Commission meeting will be areas that are underserved; Primary: Individuals or households. held on Wednesday September 27, 2017 c. identify and report on best practices Other (if applicable): None. from 12:30 p.m. until approximately for addiction prevention, including Abstract: The form allows 2:30 p.m. (Eastern Time). healthcare provider education and nonimmigrant aliens to temporarily ADDRESSES: The meeting will be held at evaluation of prescription practices, import firearms and ammunition into the Eisenhower Executive Office collaboration between State and Federal the United States for hunting or other Building, Room 350, in the Executive officials, and the use and effectiveness sporting purposes. Office of the President in Washington, of State prescription drug monitoring 5. An estimate of the total number of DC. It will be open to the public through programs; respondents and the amount of time livestreaming on https:// d. review the literature evaluating the estimated for an average respondent to www.whitehouse.gov/live. effectiveness of educational messages respond: An estimated 15,000 FOR FURTHER INFORMATION CONTACT: for youth and adults with respect to respondents will utilize the form, and it General information concerning the prescription and illicit opioids; will take each respondent Commission and its meetings can be approximately 30 minutes to complete found on ONDCP’s Web site at https:// e. identify and evaluate existing the form. www.whitehouse.gov/ondcp/presidents- Federal programs to prevent and treat 6. An estimate of the total public commission. Any member of the public drug addiction for their scope and burden (in hours) associated with the who wishes to obtain information about effectiveness, and make collection: The estimated annual public the Commission or its meetings that is recommendations for improving these burden associated with this collection is not already on ONDCP’s Web site or programs; and 7,500 hours which is equal to 15,000 who wishes to submit written comments f. make recommendations to the (the total # of respondents) * .5 (30 for the Commission’s consideration may President for improving the Federal minutes). asabaliauskas on DSKBBXCHB2PROD with NOTICES contact Michael Passante, Designated response to drug addiction and the If additional information is required Federal Officer (DFO) via email at opioid crisis. contact: Melody Braswell, Department commission@ondcp.eop.gov or Dated: September 6, 2017. Clearance Officer, United States telephone at (202) 395–6709. Please Department of Justice, Justice note that ONDCP may post such written Michael Passante, Management Division, Policy and comments publicly on our Web site, Deputy General Counsel, Designated Federal Planning Staff, Two Constitution including names and contact Officer. Square, 145 N Street NE., 3E.405A, information that are submitted. There [FR Doc. 2017–19186 Filed 9–8–17; 8:45 am] Washington, DC 20530. will not be oral comments from the BILLING CODE 3280–F5–P VerDate Sep<11>2014 16:34 Sep 08, 2017 Jkt 241001 PO 00000 Frm 00067 Fmt 4703 Sfmt 9990 E:\FR\FM\11SEN1.SGM 11SEN1


Document Created: 2017-09-09 00:04:09
Document Modified: 2017-09-09 00:04:09
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of meeting.
DatesThe Commission meeting will be held on Wednesday September 27, 2017 from 12:30 p.m. until approximately 2:30 p.m. (Eastern Time).
ContactGeneral information concerning the Commission and its meetings can be found on ONDCP's Web site at https:/ /www.whitehouse.gov/ondcp/presidents-commission. Any member of the public who wishes to obtain information about the Commission or its meetings that is not already on ONDCP's Web site or who wishes to submit written comments for the Commission's consideration may contact Michael Passante, Designated Federal Officer (DFO) via email at [email protected] or telephone at (202) 395-6709. Please note that ONDCP may post such written comments publicly on our Web site, including names and contact information that are submitted. There will not be oral comments from the public at the meeting. Requests to accommodate disabilities with respect to livestreaming or otherwise
FR Citation82 FR 42706 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR